FDA Approves OXCARBAZEPINE — Glenmark Pharmaceuticals Inc., USA

# FDA Approves Glenmark Pharmaceuticals' Generic Oxcarbazepine Glenmark Pharmaceuticals Inc., USA received FDA approval for its generic oxcarbazepine oral formulation, potentially expanding competitive options in the anticonvulsant market and creating pricing pressure on branded alternatives. The approval of Glenmark's oxcarbazepine could capture significant market share in the epilepsy and seizure disorder treatment segment as healthcare providers and patients seek cost-effective therapeutic options.